Gruenstadt, Germany

Bernd Mueller-Beckmann

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bernd Mueller-Beckmann, Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Mueller-Beckmann. Retrieved from https://idiyas.com/inventor/bernd-mueller-beckmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 1 
 
Bernd Mueller-Beckmann
 patent
silverMedal1 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Mueller-Beckmann: Inventor in Antibody Production

Introduction

Bernd Mueller-Beckmann is an inventor associated with Gruenstadt, Germany. His recorded patent concerns a method for producing human monoclonal antibodies using an immunodeficient non-human animal. He is credited with 1 patent.

Latest Patents

His listed patent, “Method for the Production of Antibodies,” describes a process that begins by introducing human fetal liver stem cells into a newborn immunodeficient animal. The resulting reconstituted animal is then exposed to an antigen. Human cells that produce antibodies against that antigen are collected, and the antibodies are isolated from those cells.

Career Highlights

The available information identifies Mueller-Beckmann as an inventor of this antibody-production method. No additional company affiliation is included here, as the supplied company entry is listed as “Other.”

Collaborations

Alexander Lifke and Valeria Lifke are identified as Mueller-Beckmann’s coworkers. The available details do not specify their roles in the patent or the invention.

Conclusion

Bernd Mueller-Beckmann’s recorded patent describes an approach to producing human monoclonal antibodies through a reconstituted immunodeficient animal, highlighting his contribution to antibody-production innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…